206 related articles for article (PubMed ID: 25917868)
1. Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial.
Mote PA; Gompel A; Howe C; Hilton HN; Sestak I; Cuzick J; Dowsett M; Hugol D; Forgez P; Byth K; Graham JD; Clarke CL
Breast Cancer Res Treat; 2015 Jun; 151(2):309-18. PubMed ID: 25917868
[TBL] [Abstract][Full Text] [Related]
2. Progesterone receptor isoform-specific promoter methylation: association of PRA promoter methylation with worse outcome in breast cancer patients.
Pathiraja TN; Shetty PB; Jelinek J; He R; Hartmaier R; Margossian AL; Hilsenbeck SG; Issa JP; Oesterreich S
Clin Cancer Res; 2011 Jun; 17(12):4177-86. PubMed ID: 21459801
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of breast cancer-associated genes by progesterone receptor isoforms PRA and PRB in a new bi-inducible breast cancer cell line.
Khan JA; Bellance C; Guiochon-Mantel A; Lombès M; Loosfelt H
PLoS One; 2012; 7(9):e45993. PubMed ID: 23029355
[TBL] [Abstract][Full Text] [Related]
4. Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis.
Mote PA; Bartow S; Tran N; Clarke CL
Breast Cancer Res Treat; 2002 Mar; 72(2):163-72. PubMed ID: 12038707
[TBL] [Abstract][Full Text] [Related]
5. Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.
Rojas PA; May M; Sequeira GR; Elia A; Alvarez M; Martínez P; Gonzalez P; Hewitt S; He X; Perou CM; Molinolo A; Gibbons L; Abba MC; Gass H; Lanari C
J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376177
[TBL] [Abstract][Full Text] [Related]
6. Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B.
Wu J; Richer J; Horwitz KB; Hyder SM
Cancer Res; 2004 Mar; 64(6):2238-44. PubMed ID: 15026368
[TBL] [Abstract][Full Text] [Related]
7. p38 and p42/44 MAPKs differentially regulate progesterone receptor A and B isoform stabilization.
Khan JA; Amazit L; Bellance C; Guiochon-Mantel A; Lombès M; Loosfelt H
Mol Endocrinol; 2011 Oct; 25(10):1710-24. PubMed ID: 21816898
[TBL] [Abstract][Full Text] [Related]
8. Effect of overexpression of progesterone receptor A on endogenous progestin-sensitive endpoints in breast cancer cells.
McGowan EM; Clarke CL
Mol Endocrinol; 1999 Oct; 13(10):1657-71. PubMed ID: 10517668
[TBL] [Abstract][Full Text] [Related]
9. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium.
Arnett-Mansfield RL; deFazio A; Wain GV; Jaworski RC; Byth K; Mote PA; Clarke CL
Cancer Res; 2001 Jun; 61(11):4576-82. PubMed ID: 11389093
[TBL] [Abstract][Full Text] [Related]
10. Altered progesterone receptor isoform expression remodels progestin responsiveness of breast cancer cells.
Graham JD; Yager ML; Hill HD; Byth K; O'Neill GM; Clarke CL
Mol Endocrinol; 2005 Nov; 19(11):2713-35. PubMed ID: 15976005
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer.
Yamashita H; Nishio M; Kobayashi S; Ando Y; Sugiura H; Zhang Z; Hamaguchi M; Mita K; Fujii Y; Iwase H
Breast Cancer Res; 2005; 7(5):R753-64. PubMed ID: 16168121
[TBL] [Abstract][Full Text] [Related]
12. Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium.
Arnett-Mansfield RL; DeFazio A; Mote PA; Clarke CL
J Clin Endocrinol Metab; 2004 Mar; 89(3):1429-42. PubMed ID: 15001645
[TBL] [Abstract][Full Text] [Related]
13. Differential quantitative proteomics reveals key proteins related to phenotypic changes of breast cancer cells expressing progesterone receptor A.
Pateetin P; Pisitkun T; McGowan E; Boonyaratanakornkit V
J Steroid Biochem Mol Biol; 2020 Apr; 198():105560. PubMed ID: 31809870
[TBL] [Abstract][Full Text] [Related]
14. Progesterone receptor isoform ratio dictates antiprogestin/progestin effects on breast cancer growth and metastases: A role for NDRG1.
Abascal MF; Elia A; Alvarez M; Pataccini G; Sequeira G; Riggio M; Figueroa V; Lamb CA; Rojas PA; Spengler E; Martínez-Vazquez P; Burruchaga J; Liguori M; Sahores A; Wargon V; Molinolo A; Hewitt S; Lombes M; Sartorius C; Vanzulli SI; Giulianelli S; Lanari C
Int J Cancer; 2022 May; 150(9):1481-1496. PubMed ID: 34935137
[TBL] [Abstract][Full Text] [Related]
15. Role of the progesterone receptor (PR) and the PR isoforms in breast cancer.
Mc Cormack O; Harrison M; Kerin MJ; McCann A
Crit Rev Oncog; 2007 Dec; 13(4):283-301. PubMed ID: 18540831
[TBL] [Abstract][Full Text] [Related]
16. Detection of progesterone receptor forms A and B by immunohistochemical analysis.
Mote PA; Johnston JF; Manninen T; Tuohimaa P; Clarke CL
J Clin Pathol; 2001 Aug; 54(8):624-30. PubMed ID: 11477119
[TBL] [Abstract][Full Text] [Related]
17. Progesterone receptor isoforms in normal and malignant breast.
Mote PA; Graham JD; Clarke CL
Ernst Schering Found Symp Proc; 2007; (1):77-107. PubMed ID: 18540569
[TBL] [Abstract][Full Text] [Related]
18. Regulation of hepatic progesterone and estrogen receptors in the female turtle, Chrysemys picta: relationship to vitellogenesis.
Custodia-Lora N; Novillo A; Callard IP
Gen Comp Endocrinol; 2004 Apr; 136(2):232-40. PubMed ID: 15028527
[TBL] [Abstract][Full Text] [Related]
19. Progesterone receptor A and B isoforms in the human breast and its disorders.
Ariga N; Suzuki T; Moriya T; Kimura M; Inoue T; Ohuchi N; Sasano H
Jpn J Cancer Res; 2001 Mar; 92(3):302-8. PubMed ID: 11267940
[TBL] [Abstract][Full Text] [Related]
20. Progesterone receptor isoforms PRA and PRB differentially contribute to breast cancer cell migration through interaction with focal adhesion kinase complexes.
Bellance C; Khan JA; Meduri G; Guiochon-Mantel A; Lombès M; Loosfelt H
Mol Biol Cell; 2013 May; 24(9):1363-74. PubMed ID: 23485561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
